• Emerging - Development stage and early commerialization stage companies
  • Strategic - IVD companies as well as diversified healthcare companies, pharmaceutical and biotechnology companies with interests and needs in clinical diagnostics
  • Financial - Venture funds, investors, private equity firms and investment banks with clinical diagnostics projects

Biomarker Strategy Development

  • Analytical instrument/system design (POC and lab systems)
  • Product road-mapping and forecasting
  • In vitro diagnostics (IVD) specialties – nucleic acid, proteomics, cell based
  • Applications is pathology, oncology, infectious diseases, cardio-vascular disease, endocrinology, diabetes
  • Strategy critique at mid-development stage
  • Competitive benchmarking

Technology, Business and Investment Scouting

  • Confidential searches and assessments
  • Efficient through technical expertise and industry relationships
  • Comprehensive financial capability and value analysis
  • Deal closing support

Business and Technical Due Diligence

  • Investment and M&A due diligence projects
  • Opportunity analysis from technical capabilities to strategic fit

Custom Competitive Intelligence

  • In depth analysis of competitors’ capabilities
  • Product cost structure and supplier analysis

Interim Executives

  • Providing interim executives in technical, sales & marketing, board and executive functions
  • Product, business and market development support


Scholz Consulting Partners LLC
54 Forest Street #323

Medford, MA 02155

Voice Mail: +1-6174181888


Print Print | Sitemap
© 2005-2019 Scholz Consulting Partners LLC